Anti-microbial resistance continues to grow as a critical healthcare crisis globally. The number of deaths attributed to this epidemic is exponentially increasing, and most measures and policies to combat AMR are deemed insufficient.
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue.
Industry leaders, innovative technology and solution providers, public authorities, international organizations, infectious disease clinicians, pharmacists and microbiologists are some of the 1,000+ attendees from over 50 countries who will gather in Washington D.C. in November 2020 at the World Anti-Microbial Resistance Congress.
The conference will gather global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on the following areas:
✔ Advancing antibiotic R&D and non-traditional therapies development
✔ Enhancing the commercial landscape and marketplace for antibiotics and diagnostics
✔ Developing innovative diagnostics solutions
✔ Conciliating funding with biotech and diagnostics innovation
✔ Improving antimicrobial stewardship guidelines and practice through technology
✔ Implementing sustainable environmental and manufacturing practices
✔ Tackling infection control at hospitals efficiently and cost-effectively
✔ Applying genomics to easily detect resistant pathogens and to accelerate antibiotic R&D
✔ Leveraging surveillance platforms and solutions to monitor outbreaks and increasing numbers of resistant pathogens locally, regionally, nationally and globally.
If you work in these key areas of AMR, then you must attend the World Anti-Microbial Resistance Congress 2020!
We look forward to meeting you in D.C. IN November